Steinger, Iscoe and Greene Files Seroquel Diabetes Lawsuit Against AstraZeneca
January 16, 2009
West Palm Beach, Florida, Jan 16 /PRNewswire/ -- Gary Iscoe, founding partner of Steinger, Iscoe and Greene, PA, one of the leading plaintiffs' litigation law firms in America, filed a lawsuit today against pharmaceutical giant AstraZeneca on behalf of a three clients whose diabetes was allegedly caused byAstraZeneca's drug Seroquel.
About Steinger, Iscoe & Greene, founded in 1997, Steinger, Iscoe & Greene is one of the leading plaintiffs' litigation law firms in America.
Seroquel (quetiapine) is a pharmaceutical drug in the class of atypical antipsychotics approved by the Food and Drug Administration in 1997. Antipsychotic drugs are used to treat symptoms of schizophrenia which include hearing voices, seeing things, sensing things that are not there, mistaken beliefs, and paranoia. Seroquel is also used in the treatment of mania associated with bipolar disorder.
Seroquel has been linked to diabetes, obesity, and high cholesterol by the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity, and the American Association of Clinical Endocrinologists.
This morning, not three or four hours ago, Bloomberg posted the following article which states:
“Jan. 16 (Bloomberg) -- AstraZeneca Plc’s antipsychotic drug Seroquel raised by almost 400 percent the risk of developing diabetes when compared with first-generation medications in its class, a doctor testified in a court case against the drugmaker.
A 2004 article published in Psychiatric Services, a journal of the American Psychiatric Association, reported the increased risk in males who were exposed to Seroquel for at least 60 days. The study, which involved 1,629 patients, compared the exposure of a newer class of antipsychotics including clozapine and Seroquel with an older class of drugs, Jennifer Marks, a Miami- based endocrinologist, said during a pre-trial hearing yesterday in federal court in Orlando, Florida.
‘Seroquel is a substantial factor in diabetes and weight gain,’ Marks said, noting the 389 percent rise.”
